Steven Altschuler - Jun 25, 2024 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Director
Signature
/s/ Youjin Choi, Attorney-in-Fact
Stock symbol
LXEO
Transactions as of
Jun 25, 2024
Transactions value $
$0
Form type
4
Date filed
6/27/2024, 05:04 PM
Previous filing
Apr 3, 2024
Next filing
Jul 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXEO Stock Option (right to buy) Award $0 +18K $0.00 18K Jun 25, 2024 Common Stock 18K $16.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 25, 2025, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date.